These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11334723)

  • 1. Value and cost evaluation of routine follow-up for patients with clinical stage I/II endometrial cancer.
    Morice P; Levy-Piedbois C; Ajaj S; Pautier P; Haie-Meder C; Lhomme C; Duvillard P; Castaigne D
    Eur J Cancer; 2001 May; 37(8):985-90. PubMed ID: 11334723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of routine follow-up procedures for patients with stage I/II cervical cancer treated with combined surgery-radiation therapy.
    Morice P; Deyrolle C; Rey A; Atallah D; Pautier P; Camatte S; Thoury A; Lhomme C; Haie-Meder C; Castaigne D
    Ann Oncol; 2004 Feb; 15(2):218-23. PubMed ID: 14760112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costs and benefits of routine follow-up after curative treatment for endometrial cancer.
    Agboola OO; Grunfeld E; Coyle D; Perry GA
    CMAJ; 1997 Oct; 157(7):879-86. PubMed ID: 9327795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
    Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of routine vaginal cytology for endometrial cancer surveillance.
    Bristow RE; Purinton SC; Santillan A; Diaz-Montes TP; Gardner GJ; Giuntoli RL
    Gynecol Oncol; 2006 Nov; 103(2):709-13. PubMed ID: 16797686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of risk factors for recurrence after treatment of endometrial uterine cancer].
    Zalewski K; Rzepka J; Madry R; Dańska-Bidzińska A; Bidzinski M
    Ginekol Pol; 2009 Sep; 80(9):687-93. PubMed ID: 19886243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Aggressive Surveillance for Locoregional Endometrial Cancer After Local Therapy.
    Yalamanchi P; Shabason JE; Zhang X; Ko EM; Lin LL
    Int J Gynecol Cancer; 2018 Sep; 28(7):1264-1270. PubMed ID: 30036223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and patterns of treatment failure in 300 consecutive cases of "early" endometrial cancer after primary surgery.
    Podczaski E; Kaminski P; Gurski K; MacNeill C; Stryker JA; Singapuri K; Hackett TE; Sorosky J; Zaino R
    Gynecol Oncol; 1992 Dec; 47(3):323-7. PubMed ID: 1473745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance procedures for patients treated for endometrial cancer: a review of the literature.
    Sartori E; Pasinetti B; Chiudinelli F; Gadducci A; Landoni F; Maggino T; Piovano E; Zola P
    Int J Gynecol Cancer; 2010 Aug; 20(6):985-92. PubMed ID: 20683406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postsurgical surveillance of patients with FIGO stage I/II endometrial adenocarcinoma.
    Berchuck A; Anspach C; Evans AC; Soper JT; Rodriguez GC; Dodge R; Robboy S; Clarke-Pearson DL
    Gynecol Oncol; 1995 Oct; 59(1):20-4. PubMed ID: 7557610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgery and postoperative radiation therapy in FIGO Stage IIIC endometrial carcinoma.
    Mundt AJ; Murphy KT; Rotmensch J; Waggoner SE; Yamada SD; Connell PP
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1154-60. PubMed ID: 11483324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrence of endometrial carcinoma and the value of routine follow up.
    Salvesen HB; Akslen LA; Iversen T; Iversen OE
    Br J Obstet Gynaecol; 1997 Nov; 104(11):1302-7. PubMed ID: 9386033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of adjuvant radiotherapy in intermediate risk endometrial cancer.
    Rankins NC; Secord AA; Jewell E; Havrilesky LJ; Soper JT; Myers E
    Gynecol Oncol; 2007 Aug; 106(2):388-93. PubMed ID: 17509672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the outcome benefit conferred by intensive surveillance strategies in women with early-stage endometrial cancer.
    Kiran G; Kesterson JP; Ozerkan K; Kanis M; Groman A; Lele S
    Eur J Gynaecol Oncol; 2013; 34(6):522-6. PubMed ID: 24601043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
    Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
    Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical value and the cost-effectiveness of follow-up in endometrial cancer patients.
    Tjalma WA; van Dam PA; Makar AP; Cruickshank DJ
    Int J Gynecol Cancer; 2004; 14(5):931-7. PubMed ID: 15361206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of histiocyte detection in Pap smears for predicting endometrial pathology. An institutional experience.
    Nassar A; Fleisher SR; Nasuti JF
    Acta Cytol; 2003; 47(5):762-7. PubMed ID: 14526675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoembryonic antigen (CEA)--a useful marker for the detection of recurrent disease in endometrial carcinoma patients.
    Bruns F; Micke O; Halek G; Schäfer U; Willich N
    Anticancer Res; 2003; 23(2A):1103-6. PubMed ID: 12820355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: report of a prospective trial.
    Eltabbakh GH; Piver MS; Hempling RE; Shin KH
    Int J Radiat Oncol Biol Phys; 1997 May; 38(2):373-80. PubMed ID: 9226326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant radiation in early stage, unfavorable histology endometrial carcinoma is associated with improved local control and survival.
    Ly D; Rowley BD; Dodson MK; Soisson PA; Jolles CJ; Gaffney DK; Sause WT
    Gynecol Oncol; 2014 May; 133(2):250-5. PubMed ID: 24589416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.